Internal Medicine, Pulmonary Disease · Tampa, FL
NPI
1740278506
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6101 Webb Rd Ste 208
Tampa, FL, 33615
Phone (813) 889-7653
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
710 services
Medicare patients, 2024
144
Average age 74
Drug cost, 2024
$1.7M
2,003 prescriptions
Company payments, 2025
$2,162
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hernan Giraldo was code 99214 (office e&m - established), 342 times for 121 patients. In total Hernan Giraldo billed 710 services in 18 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 342 | 121 | $90.06 | $31K |
| 99215 Office E&M - Established | Office | 90 | 62 | $130.11 | $12K |
| 99205 Office E&M - New | Office | 37 | 37 | $155.54 | $5,755 |
| 94664 E&M - Miscellaneous | Office | 35 | 34 | $12.32 | $431 |
| 94060 Pulmonary Function Testing | Office | 34 | 33 | $25.80 | $877 |
| 94726 Pulmonary Function Testing | Office | 34 | 33 | $36.99 | $1,258 |
| 94727 Pulmonary Function Testing | Office | 34 | 33 | $29.91 | $1,017 |
| 94729 Pulmonary Function Testing | Office | 34 | 33 | $38.43 | $1,306 |
| G0398 Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Office | 19 | 19 | $87.04 | $1,654 |
| 94660 Treatment - Miscellaneous | Office | 15 | 14 | $46.14 | $692 |
By year: 2022 $71K for 826 services; 2023 $61K for 756 services; 2024 $56K for 710 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hernan Giraldo prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 242 prescriptions and refills. In total Hernan Giraldo wrote 2,003 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 242 | 483 | 93 | $9,232 |
| Prednisone Generic | 169 | 200 | 82 | $538 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 161 | 338 | 61 | $215K |
| Fluticasone Propionate Generic | 113 | 277 | 54 | $1,835 |
| Montelukast Sodium Generic | 111 | 300 | 41 | $944 |
| Azithromycin Generic | 82 | 82 | 67 | $307 |
| Symbicort Budesonide/Formoterol Fumarate | 63 | 110 | 20 | $24K |
| Zolpidem Tartrate Generic | 59 | 66 | 14 | $243 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 57 | 112 | 24 | $10K |
| Breo Ellipta Fluticasone/Vilanterol | 48 | 82 | 14 | $32K |
| Eszopiclone Generic | 36 | 37 | Under 11 | $545 |
| Fasenra Benralizumab | 36 | 67 | Under 11 | $220K |
| Famotidine Generic | 36 | 79 | 15 | $510 |
| Ventolin Hfa Albuterol Sulfate | 29 | 53 | 18 | $2,938 |
| Spiriva Respimat Tiotropium Bromide | 27 | 58 | 11 | $30K |
Brand drugs: - claims; generic drugs: 1,247 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hernan Giraldo $2,162 ($2,162 in general payments such as food, travel and fees) from 13 companies. The largest payer was GlaxoSmithKline, LLC. with $790.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 33 | $790 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $305 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $293 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $200 |
| Genzyme Corporation SNY | 5 | $144 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $72.43 |
| Harmony Biosciences LLC HRMY | 2 | $44.57 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $29.97 |
| Merck Sharp & Dohme LLC MRK | 1 | $27.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.